Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors

Several β-secretase (BACE) inhibitors exhibit unexplained ocular toxicity in preclinical studies. Here the authors generate a clickable photoaffinity probe to interrogate off-targets in cells and animals, and identify inhibition of cathepsin D as a driver of ocular toxicity.

Bibliographic Details
Main Authors: Andrea M. Zuhl, Charles E. Nolan, Michael A. Brodney, Sherry Niessen, Kevin Atchison, Christopher Houle, David A. Karanian, Claude Ambroise, Jeffrey W. Brulet, Elizabeth M. Beck, Shawn D. Doran, Brian T. O’Neill, Christopher W. am Ende, Cheng Chang, Kieran F. Geoghegan, Graham M. West, Joshua C. Judkins, Xinjun Hou, David R. Riddell, Douglas S. Johnson
Format: Article
Language:English
Published: Nature Portfolio 2016-10-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/ncomms13042
_version_ 1818978516032552960
author Andrea M. Zuhl
Charles E. Nolan
Michael A. Brodney
Sherry Niessen
Kevin Atchison
Christopher Houle
David A. Karanian
Claude Ambroise
Jeffrey W. Brulet
Elizabeth M. Beck
Shawn D. Doran
Brian T. O’Neill
Christopher W. am Ende
Cheng Chang
Kieran F. Geoghegan
Graham M. West
Joshua C. Judkins
Xinjun Hou
David R. Riddell
Douglas S. Johnson
author_facet Andrea M. Zuhl
Charles E. Nolan
Michael A. Brodney
Sherry Niessen
Kevin Atchison
Christopher Houle
David A. Karanian
Claude Ambroise
Jeffrey W. Brulet
Elizabeth M. Beck
Shawn D. Doran
Brian T. O’Neill
Christopher W. am Ende
Cheng Chang
Kieran F. Geoghegan
Graham M. West
Joshua C. Judkins
Xinjun Hou
David R. Riddell
Douglas S. Johnson
author_sort Andrea M. Zuhl
collection DOAJ
description Several β-secretase (BACE) inhibitors exhibit unexplained ocular toxicity in preclinical studies. Here the authors generate a clickable photoaffinity probe to interrogate off-targets in cells and animals, and identify inhibition of cathepsin D as a driver of ocular toxicity.
first_indexed 2024-12-20T16:44:52Z
format Article
id doaj.art-5dfe4a29e6af43a49ee6c24207abc513
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-20T16:44:52Z
publishDate 2016-10-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-5dfe4a29e6af43a49ee6c24207abc5132022-12-21T19:32:57ZengNature PortfolioNature Communications2041-17232016-10-017111410.1038/ncomms13042Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitorsAndrea M. Zuhl0Charles E. Nolan1Michael A. Brodney2Sherry Niessen3Kevin Atchison4Christopher Houle5David A. Karanian6Claude Ambroise7Jeffrey W. Brulet8Elizabeth M. Beck9Shawn D. Doran10Brian T. O’Neill11Christopher W. am Ende12Cheng Chang13Kieran F. Geoghegan14Graham M. West15Joshua C. Judkins16Xinjun Hou17David R. Riddell18Douglas S. Johnson19Pfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentWorldwide Medicinal ChemistryPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentWorldwide Medicinal ChemistryWorldwide Medicinal ChemistryPfizer Worldwide Research and DevelopmentWorldwide Medicinal ChemistryWorldwide Medicinal ChemistryPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentPfizer Worldwide Research and DevelopmentSeveral β-secretase (BACE) inhibitors exhibit unexplained ocular toxicity in preclinical studies. Here the authors generate a clickable photoaffinity probe to interrogate off-targets in cells and animals, and identify inhibition of cathepsin D as a driver of ocular toxicity.https://doi.org/10.1038/ncomms13042
spellingShingle Andrea M. Zuhl
Charles E. Nolan
Michael A. Brodney
Sherry Niessen
Kevin Atchison
Christopher Houle
David A. Karanian
Claude Ambroise
Jeffrey W. Brulet
Elizabeth M. Beck
Shawn D. Doran
Brian T. O’Neill
Christopher W. am Ende
Cheng Chang
Kieran F. Geoghegan
Graham M. West
Joshua C. Judkins
Xinjun Hou
David R. Riddell
Douglas S. Johnson
Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
Nature Communications
title Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
title_full Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
title_fullStr Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
title_full_unstemmed Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
title_short Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
title_sort chemoproteomic profiling reveals that cathepsin d off target activity drives ocular toxicity of β secretase inhibitors
url https://doi.org/10.1038/ncomms13042
work_keys_str_mv AT andreamzuhl chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT charlesenolan chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT michaelabrodney chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT sherryniessen chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT kevinatchison chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT christopherhoule chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT davidakaranian chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT claudeambroise chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT jeffreywbrulet chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT elizabethmbeck chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT shawnddoran chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT briantoneill chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT christopherwamende chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT chengchang chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT kieranfgeoghegan chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT grahammwest chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT joshuacjudkins chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT xinjunhou chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT davidrriddell chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors
AT douglassjohnson chemoproteomicprofilingrevealsthatcathepsindofftargetactivitydrivesoculartoxicityofbsecretaseinhibitors